ZLN005
- ₹7144.5 - ₹28956.88
- Product name: ZLN005
- CAS: 49671-76-3
- MF: C17H18N2
- MW: 250.34
- EINECS:
- MDL Number:MFCD01560221
- Synonyms:2-(4-TERT-BUTYLPHENYL)-1H-BENZO[D]IMIDAZOLE;2-(4-tert-Butylphenyl)-1H-benzimidazole;2-(4-tert-Butylphenyl)benzimidazole;ZLN005, >=98%;2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazole;2-(4-tert-Butylphenyl)benzimidazole ZLN005;ZLN005 2-(4-tert-Butylphenyl)benzimidazole;ZLN005
2 prices
Selected condition:
Brand
- Sigma-Aldrich(India)
Package
- 10MG
- 50MG
- ManufacturerSigma-Aldrich(India)
- Product numberSML0802
- Product descriptionZLN005 ≥95% (HPLC)
- Packaging10MG
- Price₹7144.5
- Updated2022-06-14
- Buy
- ManufacturerSigma-Aldrich(India)
- Product numberSML0802
- Product descriptionZLN005 ≥95% (HPLC)
- Packaging50MG
- Price₹28956.88
- Updated2022-06-14
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich(India) | SML0802 | ZLN005 ≥95% (HPLC) | 10MG | ₹7144.5 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | SML0802 | ZLN005 ≥95% (HPLC) | 50MG | ₹28956.88 | 2022-06-14 | Buy |
Properties
Melting point :257-258℃
Boiling point :415.3±38.0 °C(Predicted)
Density :1.102±0.06 g/cm3(Predicted)
storage temp. :Sealed in dry,Store in freezer, under -20°C
solubility :DMSO: soluble10mg/mL, clear
pka :11.52±0.10(Predicted)
form :powder
color :white to beige
Boiling point :415.3±38.0 °C(Predicted)
Density :1.102±0.06 g/cm3(Predicted)
storage temp. :Sealed in dry,Store in freezer, under -20°C
solubility :DMSO: soluble10mg/mL, clear
pka :11.52±0.10(Predicted)
form :powder
color :white to beige
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|
Description
Peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) is a tissue-specific and inducible transcriptional coactivator for several nuclear receptors and plays a key role in energy metabolism, hepatic gluconeogenesis, and cholesterol homoeostasis. ZLN005 is a small molecule that stimulates the expression of PGC-1α and downstream genes in skeletal muscle cells, improving glucose utilization and fatty acid oxidation at a concentration of 20 μM. Chronic administration of 15 mg/kg/day ZLN005 to diabetic db/db mice increased PGC-1α and downstream gene transcription in skeletal muscle, increasing fat oxidation and improving glucose tolerance, pyruvate tolerance, and insulin sensitivity.More related product prices
PD 98059 T0070907 Saracatinib 49843-98-3 BAY 11-7082 Doxorubicin hydrochloride Crenolanib AZD-1208 Ilomastat L-4-THIAZOLYLALANINE 4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide PF-04929113 IXABEPILONE OTAVA-BB 1115529 Tariquidar Esomeprazole magnesium BLU 9931 Rosiglitazone maleate 1181226-02-7Related product price
- PD 98059
₹6400-32230 - T0070907
₹19116.95-70925.4 - 49843-98-3
₹12697.73-49437.78